Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing

Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics Testing

As recognised by the National Institutes of Health (NIH) Precision Medicine Initiative (PMI), microarray technology currently provides a rapid, inexpensive means of identifying large numbers of known genomic variants or gene transcripts in experimental and clinical settings. However new generation s...

Full description

Bibliographic Details
Main Authors: Shahandeh, Al, Johnstone, Daniel M., Atkins, Joshua R., Sontag, Jean-Marie, Heidari, Moones, Daneshi, Nilofar, Freeman-Acquah, Elvis, Milward, Elizabeth A.
Format: Online
Language:English
Published: MDPI 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003488/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003488/

Similar Items